Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

Br J Haematol. 2015 Apr;169(2):293-6. doi: 10.1111/bjh.13199. Epub 2014 Nov 5.
No abstract available

Keywords: growth factors; stem cell mobilization/homing; stem cell transplantation.

Publication types

  • Letter

MeSH terms

  • Biosimilar Pharmaceuticals / administration & dosage
  • Biosimilar Pharmaceuticals / chemistry
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Chemistry, Pharmaceutical
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Granulocyte Colony-Stimulating Factor / chemistry
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Italy
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / therapeutic use
  • Retrospective Studies
  • Transplantation, Autologous

Substances

  • Biosimilar Pharmaceuticals
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim